NASA Seeking: Drug Repurposing Organizations

Overview:

NASA is seeking to identify organizations (non-profits, academia, companies, government etc.) specializing in discovering new therapeutic uses for existing approved or investigational drugs, with the goal of reducing R&D time and cost, minimizing general adverse effects risks, and improving clinical success rates by leveraging AI, real-world and translational science data.

Background:

Drug repurposing is a major focus in pharmaceutical R&D as they drive accelerated drug discovery, aimed at finding new uses for approved, investigational, or even failed drugs, thereby reducing development time and costs. NASA would like to leverage the expertise of biotech companies, AI-driven firms and large pharmaceutical companies to identify repurposed drugs for space radiation-induced adverse impacts on human health.

Areas of Interest:

• Priority will be given to:
  • Repurposed drugs that address radiation induced cancers, including prevention (for example, lung, breast, ovarian, colon), cardiovascular disease and indications affecting the central nervous system.
  • US based institutions (however institutions based outside the US are not out of scope)
• Also of interest are the AI platforms used for screening therapeutics

Desired outcome of the solution:

• NASA is seeking to partner with an organization to accelerate the approval of therapeutics of interest.

Related TechNeeds:

NASA Seeking: Crew Connectedness Advanced Communication Platform for Deep-Space Exploration

NASA Seeking: Fire Residue Cleanup Technologies To Be Used In a Sealed Spacecraft

NASA Seeking: Non-invasive Neuromodulation Technologies for Astronaut Performance and Behavioral Health

Image by FreePik